(Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, in a strategic partnership with Simcere Zaiming to develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors
after which I found their music not disagreeable
I presented initial findings at the Fourth biennial Faith and Knowledge Conference, hosted at Wesley Theological Seminary, Washington DC, in 2013, with a follow-up in the Latter-day Saints and the Bible section of the annual meeting of the Society of Biblical Literature and American Academy of Religion in 2019
Designed to be repurposed as a tealight holder, catchall or decorative glass accent after use
Lets jump right in
Hopefully, it will not take a kinetic war to bring needed change today